2Ho CT, Mok CC, Lau CS, et al. Late onset systemic lupus erythematosus in southern Chinese [ J ]. Ann Rheum Dis, 1998,57(7) :437-440.
3Antolin J, Amerigo M J, Cantabrana A, et al. Systemic lupus erythematosus: clinical manifestations and im- munological parameters in 194 patients. Subgroup classification of SLE [J]. Clin Rheumatol,1995,14(6) :678-685.
4Maddison P, Farewell V, Isenberg D,et al. The rate and pattern of organ damage in late onset systemic lupus erythematosus [ J]. J Rheumatol, 2002,29(5) :913-917.
5Costallat LT, Coimbra AM. Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset [ J ]. Clin Exp Rheumatol, 1994,12 (6) : 603-607.
6Nived O, Jonsen A, Bengtsson AA, et al. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus [ J ]. J Rheumatol, 2002, 29 ( 7 ) : 1398-1400.
7Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1 000 patients. The European Working Party on Systemic Lupus Erythematosus[ J]. Medicine (Baltimore) , 1993,72(2) : 113-124.
8Wilson HA, Hamilton ME, Spyker DA, et al. Age influences the clinical and serologic expression of systemic lupus erythematosus [ J ]. Arthritis Rheum, 1981,24(10) : 1230-1235.
9Manoussakis MN, Georgopoulou C, Zintzaras E, et al. Sjogren's syndrome associated with systemic lupus erythematosus. Clinical and laboratory profiles and comparison with primary Sjogren's syndrome[ J]. Arthritis Rheum,2004,50(3) :882-891.
10Anolik JH, Aringer M. New treatments for SLE: cell-depleting and anti-cytokine therapies [ J ]. Best Pract Res Clin Rheumato, 2005, 19 (5) : 859-878.
二级参考文献16
1Hochberg MC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum,1997,40:1725.
2Wilson WA,Gharavi AE,Koike T,et al.International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome.Report of an international workshop.Arthritis Rheum,1999,42:1309～1311.
3Urowitz MB,Stevens MB,Shulman LE.The influence of age on the clinical pattern of systemic lupus erythematosus.Arthritis Rheum,1967,10:319.
4Jacobsen S,Petersen J,Ullman S,et al.A multicentre study of513 Danish patients with systemic lupus erythematosus.I.Disease manifestations and analyses of clinical subsets.Clin Rheumatol,1998,17:468～477.
5Cervera R,Khamashta MA,Font J,et al.European Working Party on Systemic Lupus Erythematosus.Morbidity and mortality in systemic lupus erythematosus during a 10-year period:a comparison of early and late manifestations in a cohort of 1,000patients.Medicine (Baltimore),2003,82:299～308.
6Antolin J,Amerigo M J,Cantabrana A,et al.Systemic lupus erythematosus:clinical manifestations and immunological parameters in 194 patients.Subgroup classification of SLE.Clin Rheumatol,1995,14:678～685.
7Formiga F,Moga I,Pac M,et al.Mild presen-tation of systemic lupus erythematosus in elderly patients assessed by SLEDA1.Lupus,1999,8:462～465.
8Bynoe MS,Grimaldi CM,Diamond B.Estrogen up-regulates Bcl-2and blocks tolerance induction of naive B cells.Proc Natl Acad Sci USA.2000,97:2703～2708.
9Costallat LTL,Coimbra AMV.Systemic lupus erythematosus:clinical and laboratory aspects related to age at disease onset.Clin ExpRheumatol,1994,12:603～607.
10Jacobsen S,Petersen J,Ullman S,et al.A multicentre study of 513 Danish patients with systemic lupus erythematosus.I.Disease manifestations and analyses of clinical subsets.Clin Rheumatol,1998,17:468～477.
